{"id":"W3088611248","doi":"10.1016/j.annonc.2020.08.2296","title":"LBA6_PR Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Internal medicine; Interim analysis; Cancer; Oncology; FOLFOX; Randomized controlled trial; Population; Ipilimumab; Gastroesophageal Junction; Chemotherapy; Gastroenterology; Adenocarcinoma; Oxaliplatin; Immunotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002890394,0.0005029516,0.001381367,0.0001721916,0.0001964146,0.00001341998,0.0004176506,0.0001944736,0.00022879],"category_scores_gemma":[0.0002102302,0.0003892095,0.0005064989,0.0008258548,0.0001959859,0.0001301999,0.0001540139,0.0002534984,0.000007610714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008415638,"about_ca_system_score_gemma":0.0007387254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002822752,"about_ca_topic_score_gemma":0.002478211,"domain_scores_codex":[0.9968984,0.00007998818,0.001038306,0.0007745412,0.0005195164,0.0006892573],"domain_scores_gemma":[0.9975133,0.0002608051,0.000944528,0.0006114694,0.0004245061,0.0002454252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2632803,0.007285678,0.1887269,0.001776844,0.007360672,0.0003062324,0.01428745,0.01030429,0.002120924,0.00008358709,0.05906215,0.4454049],"study_design_scores_gemma":[0.2739838,0.1118823,0.4699653,0.0003570802,0.003489362,0.00003615024,0.003349708,0.003657916,0.04370877,0.00005864128,0.08864015,0.0008707935],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9551005,0.002560543,0.00008509854,0.03615841,0.001244259,0.003804507,0.0002040893,0.00008432836,0.0007582626],"genre_scores_gemma":[0.9917319,0.002836987,0.0002994366,0.001793681,0.0008231258,0.0006200874,0.00006169292,0.00006961281,0.001763487],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4445341,"threshold_uncertainty_score":0.999856,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.103485147283131,"score_gpt":0.3842591844838083,"score_spread":0.2807740372006773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}